Zobrazeno 1 - 8
of 8
pro vyhledávání: '"A. Seun Ajiboye"'
Publikováno v:
Lancet (London, England). 395(10224)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f9a76567f398b9ab65d5fa8028286a0
https://pubmed.ncbi.nlm.nih.gov/32087791
https://pubmed.ncbi.nlm.nih.gov/32087791
Autor:
Janet Mendonca, David Smith, Amanda L. Blackford, Daniel C. Danila, Sushant Kachhap, Elisabeth I. Heath, Serina King, Emmanuel S. Antonarakis, A. Seun Ajiboye, Michael A. Carducci, Michelle A. Rudek, Ming Zhao, Dana E. Rathkopf, AS Frost
Publikováno v:
The Oncologist. 18:163-173
Background. The antifungal drug itraconazole inhibits angiogenesis and Hedgehog signaling and delays tumor growth in murine prostate cancer xenograft models. We conducted a noncomparative, randomized, phase II study evaluating the antitumor efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5a706dcc8753fe3f57b28a9dd47483c
https://doi.org/10.1634/theoncologist.2012-314
https://doi.org/10.1634/theoncologist.2012-314
Publikováno v:
BJU International. 105:913-916
The type III transforming growth factor-beta receptor (TGFbetaR3, betaglycan), a tumour suppressor, is the most frequently lost TGFbeta pathway component. This event appears to be very important in the transition of the TGFbeta pathway from having tu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d81e09ef8f2c086ec82787368154255
https://doi.org/10.1111/j.1464-410x.2009.08999.x
https://doi.org/10.1111/j.1464-410x.2009.08999.x
Autor:
Haiyi Cao, Srinivasan Yegnasubramanian, Samuel R. Denmeade, Michael A. Carducci, A. Seun Ajiboye, Michael C. Haffner, Jun Luo, John T. Isaacs, Emmanuel S. Antonarakis, Michael T. Schweizer, Mario A. Eisenberger, Hao Wang, Avery Spitz
Publikováno v:
Science Translational Medicine. 7
Targeting androgen receptor (AR) axis signaling by disrupting androgen-AR interactions remains the primary treatment for metastatic prostate cancer. Unfortunately, all men develop resistance to primary castrating therapy and secondary androgen depriv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db26fa0fc495649c44881659765d51a0
https://doi.org/10.1126/scitranslmed.3010563
https://doi.org/10.1126/scitranslmed.3010563
Autor:
Howard L. Parnes, Philip M. Arlen, Douglas K. Price, Seth M. Steinberg, Sukyung Woo, James L. Gulley, William D. Figg, John J. Wright, A. Seun Ajiboye, Xiaohong Chen, Wenhui Zhu, William L. Dahut
Publikováno v:
The Journal of urology. 183(6)
This phase I study of high dose ketoconazole and docetaxel was designed against castration resistant prostate cancer to determine the maximum tolerated doses, side effects, and pharmacokinetic interaction of co-administered docetaxel and ketoconazole
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de488dc5344e70ecaac417ec0e209e65
https://pubmed.ncbi.nlm.nih.gov/20399458
https://pubmed.ncbi.nlm.nih.gov/20399458
Autor:
Janet Mendonca, David Smith, Daniel C. Danila, Elisabeth I. Heath, Emmanuel S. Antonarakis, AS Frost, Sushant Kachhap, A. Seun Ajiboye, Serina King, Michael A. Carducci, Amanda L. Blackford, Michelle A. Rudek, Ming Zhao, Dana E. Rathkopf
Publikováno v:
Cancer Research. 72:LB-224
BACKGROUND: The antifungal drug itraconazole inhibits angiogenesis and Hedgehog signaling, and delays tumor growth in murine prostate cancer xenograft models. Unlike ketoconazole, it does not suppress androgen synthesis. METHODS: A phase 2 study of o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6a82e95581a42301bd2a02fa520d312
https://doi.org/10.1158/1538-7445.am2012-lb-224
https://doi.org/10.1158/1538-7445.am2012-lb-224
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.